ЛАБОРАТОРНАЯ ДИАГНОСТИКА НАРУШЕНИЙ СИСТЕМЫ ГЕМОСТАЗА — СКРИНИНГОВЫЕ ТЕСТЫ
https://doi.org/10.15829/1560-4071-2015-3-52-57
Аннотация
В обзоре обсуждается диагностическая значимость основных скрининговых коагулогических тестов в свете современных представлений о роли компонентов стенки сосудов, белков плазмы и клеток крови в динамике образования тромбина и регуляции его активностей.
Об авторах
А. Б. Добровольский
ФГБУ Российский кардиологический научно-производственный комплекс МЗ РФ, Москва
Россия
Россия
д.б.н., профессор, в.н.с. лаборатории клинических проблем атеротромбоза
Е. В. Титаева
ФГБУ Российский кардиологический научно-производственный комплекс МЗ РФ, Москва
Россия
к.б.н., с.н.с. лаборатории клинических проблем атеротромбоза
Россия
к.б.н., с.н.с. лаборатории клинических проблем атеротромбоза
Список литературы
1. Mann KG, Brummel K, Butenas S . What is all that thrombin for? J Thromb Haemost 2003; 1: 1504-14.
2. Crawley JTB, Zanardelli S, Chion CKNK, et al.The central role of thrombin in hemostasis. J T hromb Haemost 2007; 5: 95-101.
3. Furie B., Furie B. C. Mechanisms of Thrombus Formation. N Engl J Med 2008; 359: 938-49.
4. Maureen McMichael. New Models of Hemostasis. Topics in Companion An Med 27 (2012) 40-45.
5. Versteeg HH, Heemskerk JWM, Levi M, et al. New Fundamentals in Hemostasis. Physiol Rev 2013; 93: 327-58.
6. Butenas S, Mann KG. Blood coagulation (review). Biochemistry (Moscow) 2002; 67: 5-15. Russian (Бутенас С ., Манн КГ. Свертывание крови (обзор). Биохимия 2002, 67, 5-15).
7. Di Nisio M, Baudo F, Cosmi B, et al. on behalf of the Italian Society for Thrombosis and Haemostasis. Diagnosis and treatment of disseminated intravascular coagulation: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res 2011doi: 10.1016/j.thormbres.2011.08.028.
8. Kaptoge S ., Di Angelantonio E., Pennells L. The Emerging Risk Factors Collaboration. C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction. N Engl J Med. 2012; 367(14): 1310-20.
9. Ariens R. A.S. Fibrin(ogen) and thrombotic disease. J Thromb Haemost 2013; 11 (Suppl. 1) 294-305.
10. Turpie A. G .G., Esmon C. Venous and arterial thrombosis — pathogenesis and the rationale for anticoagulation. Thromb Haemost 2011; 105: 586-96.
11. Mahmoodi BK, Brouwer JL, Veeger NJ, et al. Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study. Circulation 2008; 118: 1659-67.
12. Kenet G, Lütkhoff LK, Albisetti M, et al. Impact of thrombophilia on risk or arterial stroke or cerebral sinovenous thrombosis in neonates and children: A systematic review and metaanalysis of observational studies. Circulation 2010; 121: 1838-47.
13. Yilmaza S, Gunaydin S . Inherited risk factors in low-risk venous thromboembolism in patients under 45 years. Interactive CardioVascular and Thoracic Surgery 2015; 20: 21-3.
14. Keeling D . Thrombophilia screening or screaming. J Thromb Haemost 2010; 8: 1191-2.
15. Lijfering WM, Brouwer J-LP, Veeger NJGM, et al. Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood. 2009; 113: 5314-22.
16. Ruff CT, Giugliano RP, Braunwald E. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 2013; published online Dec 4. http://dx.doi.org/10.1016/ S0140-6736(13)62343-0.
17. Pabinger I, Vossen CY, Lang J, et al. Mortality and Inherited Thrombophilia: results from the European Prospective Cohort on Thrombophilia (EPCOT). J Thromb Haemost 2012; 10: 217-22.
18. Christiansen SC, Cannegieter SC, Koster T, et al. Thrombophilia, clinical factors, and recurrent venous thrombotic events. J Am Med Assoc 2005; 293: 2352-61.
19. Righini M, Perrier A, De Moerloose P, et al. D-Dimer for venous thromboembolism diagnosis: 20 years later. J Thromb Haemost 2008; 6: 1059-71.
20. Dobrovolsky AB, Titaeva EV. Haemostatic risk factors of thrombosis and laboratory control of anticoagulant therapy. Atherothrombosis 2009; 2 (1): 2-14. Russian (Добровольский А. Б ., Титаева Е. В. Коагулогические факторы риска тромбозов и лабораторный контроль антикоагулянтной терапии. Атеротромбоз, 2009, 2, 1, 2-14).
21. Vorobyeva NM, Panchenko EP, Dobrovolskyi AB, et al. Factors associated with D-dimer elevation in patients with venous thromboembolic events. Russ J Cardiol 2012; 4(96): 18-24. Russian (Воробьёва Н. М., Панченко Е. П., Добровольский А. Б ., и др. Факторы, ассоциирующиеся с повышением Д-димера у больных венозными тромбоэмболическими осложнениями. Российский кардиологический журнал 2012; 4(96): 18-24).
22. de Bastos MRD, Bogutchi T, Carneiro-Proietti ABF, et al. Duration of symptoms and D-dimer testing in the ruling-out of venous thromboembolism. J Thromb Haemost 2006; 4: 2079-80.
23. Vorobjeva NM, Panchenko EP, Dobrovolskii АВ, Titaeva EV. Elevated D-dimer in patients with cardiovascular diseases free from thromboembolic complications: what is it associated with and what has to be done? Angiology and Vascular Surgery 2010; 16 (4): 34-42. Russian (Воробьёва Н. М., Панченко Е. П., Добровольский А. Б ., Титаева Е. В. Повышение Д-димера у больных сердечно-сосудистыми заболеваниями без тромбоэмболических осложнений: с чем это связано и что делать? Ангиология и сосудистая хирургия 2010; 16 (4): 34-42).
24. Douma RA, Tan M, Schutgens REG, et al. Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded. Haematologica 2012; 97(10): 1507-13.
25. Palareti G, Cosmi B, Legnani C, et al. for the PROLONG Investigators. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med 2006; 355: 1780-9.
26. Eichinger S, Heinze G, Jandeck LM, et al. Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary Embolism. The Vienna Prediction Model. Circulation 2010; 121: 1630-6.
27. Tosetto A, Iorio A, Marcucci M, et al. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). J T hromb Haemost 2012; 10: 1019-5.
28. Lowe G, Rumley A. The relevance of coagulation in cardiovascular disease: what do the biomarkers tell us? Thromb Haemost 2014; 112: 860-7.
29. Christersson C, Wallentin L, Andersson U, et al. D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation — observations from the ARISTOTLE trial. J Thromb Haemost. 2014; 12: 1401-12.
30. Castelnuovo A, Agnoli C, de Curtis A, et al. Elevated levels of D-dimers increase the risk of ischaemic and haemorrhagic stroke Findings from the EPICOR Study. Thromb Haemost 2014; 112: 941-6.
Рецензия
Для цитирования:
Добровольский А.Б., Титаева Е.В. ЛАБОРАТОРНАЯ ДИАГНОСТИКА НАРУШЕНИЙ СИСТЕМЫ ГЕМОСТАЗА — СКРИНИНГОВЫЕ ТЕСТЫ. Российский кардиологический журнал. 2015;(3):52-57. https://doi.org/10.15829/1560-4071-2015-3-52-57
For citation:
Dobrovolsky A.B., Titaeva E.V. SCREENING OF CLOTTING SYSTEM DISORDERS BY LABORATORY TESTS. Russian Journal of Cardiology. 2015;(3):52-57. (In Russ.) https://doi.org/10.15829/1560-4071-2015-3-52-57
Просмотров:
1056
Послать статью по эл. почте 